Biondo Investment Advisors’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-182,555
| Closed | -$3.04M | – | 79 |
|
2022
Q1 | $3.04M | Buy |
182,555
+5,092
| +3% | +$84.8K | 0.54% | 45 |
|
2021
Q4 | $3.39M | Buy |
177,463
+626
| +0.4% | +$12K | 0.56% | 44 |
|
2021
Q3 | $4.36M | Buy |
176,837
+3,146
| +2% | +$77.6K | 0.75% | 44 |
|
2021
Q2 | $4.52M | Buy |
173,691
+932
| +0.5% | +$24.2K | 0.78% | 44 |
|
2021
Q1 | $5.47M | Sell |
172,759
-624
| -0.4% | -$19.8K | 1.09% | 39 |
|
2020
Q4 | $8.05M | Sell |
173,383
-8,790
| -5% | -$408K | 1.54% | 19 |
|
2020
Q3 | $6M | Sell |
182,173
-315
| -0.2% | -$10.4K | 1.3% | 23 |
|
2020
Q2 | $5.01M | Buy |
182,488
+3,089
| +2% | +$84.8K | 1.26% | 29 |
|
2020
Q1 | $5.37M | Sell |
179,399
-4,686
| -3% | -$140K | 1.78% | 15 |
|
2019
Q4 | $5.1M | Sell |
184,085
-750
| -0.4% | -$20.8K | 1.18% | 30 |
|
2019
Q3 | $3.36M | Buy |
+184,835
| New | +$3.36M | 0.86% | 38 |
|